Controlled release hydrocodone formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7514100
APP PUB NO 20040047907A1
SERIAL NO

10660349

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PURDUE PHARMA L.P.STAMFORD, CT401

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Hua-Pin Englewood Cliffs, US 54 2273
Masselink, John K Old Tappan , US 24 712
Oshlack, Benjamin New York , US 217 11620
Tonelli, Alfred P Congers, US 15 807

Cited Art Landscape

Patent Info (Count) # Cites Year
 
PHARMACIA & UPJOHN AB (1)
5614218 Controlled release preparation 66 1994
 
Duphar International Research B.V. (1)
5219575 Compositions with controlled zero-order delivery rate and method of preparing these compositions 43 1990
 
RIJKSUNIVERSITEIT GRONINGEN (1)
4708874 Devices for the controlled release of active substances, as well as process for the preparation thereof 80 1986
 
DEUTSCHE BANK AG NEW YORK BRANCH (1)
4983730 Water soluble cellulose acetate composition having improved processability and tensile properties 81 1988
 
RICHARDSON-VICKS INC. (1)
4996047 Sustained release drug-resin complexes 116 1988
 
VALEANT INTERNATIONAL BERMUDA (1)
5518730 Biodegradable controlled release flash flow melt-spun delivery system 232 1992
 
ALZA CORPORATION (7)
5019397 Aqueous emulsion for pharmaceutical dosage form 113 1988
5024842 Annealed coats 105 1990
5460826 Morphine therapy 145 1994
6491945 Hydrocodone therapy 60 1994
5593695 Morphine therapy 85 1995
5866161 Hydrocodone therapy 77 1996
5667805 Morphine therapy 75 1996
 
ELAN CORPORATION, PLC (2)
4609542 New pharmaceutical forms for administration of medicaments by oral route, with programmed release 51 1985
5637320 Controlled absorption naproxen formulation for once-daily administration 69 1994
 
MERRELL DOW PHARMACEUTICALS INC. (1)
4421736 Sustained release diethylpropion compositions 79 1982
 
NIRO HOLDING A/S (1)
5030400 Process and an apparatus for agglomeration of a powdery material 85 1990
 
EURO-CELTIQUE S.A. (12)
4443428 Extended action controlled release compositions 149 1982
* 4844907 Pharmaceutical composition comprising analgesic and anti-inflammatory agent 155 1986
5071646 Pharmaceutical ion exchange resin composition 153 1989
5356467 Controlled release coatings derived from aqueous dispersions of zein 232 1993
5500227 Immediate release tablet cores of insoluble drugs having sustained-release coating 208 1993
5670172 Pharmaceutical spheroid formulation 105 1995
5849240 Method of preparing sustained release pharmaceutical compositions 189 1996
5891471 Pharmaceutical multiparticulates 165 1996
5843480 Controlled release diamorphine formulation 133 1996
5879705 Sustained release compositions of morphine and a method of preparing pharmaceutical compositions 175 1997
5965163 Substained release compositions and a method of preparing pharmaceutical compositions 176 1997
6572885 Orally administrable opioid formulations having extended duration of effect 112 2001
 
PURDUE PHARMA L.P. (25)
4828836 Controlled release pharmaceutical composition 226 1987
4834985 Controlled release pharmaceutical composition 238 1987
4990341 Controlled release hydromorphone composition 193 1989
5266331 Controlled release oxycodone compositions 267 1991
5273760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 274 1991
5286493 Stabilized controlled release formulations having acrylic polymer coating 270 1992
5549912 Controlled release oxycodone compositions 260 1993
5472712 Controlled-release formulations coated with aqueous dispersions of ethylcellulose 259 1993
5580578 Controlled release formulations coated with aqueous dispersions of acrylic polymers 243 1993
5478577 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level 275 1993
5411745 Powder-layered morphine sulfate formulations 168 1994
5965161 Extruded multi-particulates 209 1994
5639476 Controlled release formulations coated with aqueous dispersions of acrylic polymers 548 1995
5508042 Controlled release oxycodone compositions 287 1995
5968551 Orally administrable opioid formulations having extended duration of effect 275 1995
5958459 Opioid formulations having extended controlled released 183 1995
5656295 Controlled release oxycodone compositions 245 1996
5681585 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 155 1996
5672360 Method of treating pain by administering 24 hour oral opioid formulations 255 1996
6143322 Method of treating humans with opioid formulations having extended controlled release 188 1997
5958452 Extruded orally administrable opioid formulations 242 1997
6103261 Opioid formulations having extended controlled release 177 1999
6294195 Orally administrable opioid formulations having extended duration of effect 166 1999
* 6733783 Controlled release hydrocodone formulations 180 2001
2004/0266,807 Controlled release hydrocodone formulations 72 2004
 
ASAHI KASEI CHEMICALS CORPORATION (1)
5384130 Spherical seed cores, spherical granules and process for production thereof 65 1993
 
VIRGINIA COMMONWEALTH UNIVERSITY (2)
5321012 Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance 190 1993
5502058 Method for the treatment of pain 168 1994
 
EUROCELTIQUE S.A., 122, BOULEVARD DE LA PETRUSSE, LUXEMBOURG (1)
4844909 Controlled release hydromorphone composition 184 1987
 
PFIZER INC. (1)
4861596 Rolled matrix device having enhanced ability to unroll and method for its production 29 1988
 
NIPPON SHINYAKU CO., LTD. (1)
5456923 Method of manufacturing solid dispersion 167 1993
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
5026560 Spherical granules having core and their production 172 1988
 
GRUENENTHAL GMBH (1)
5601842 Sustained release drug formulation containing a tramadol salt 85 1996
 
ALPHARMA PHARMACEUTICALS, LLC (3)
5202128 Sustained release pharmaceutical composition 198 1990
5330766 Sustained release pharmaceutical composition 163 1993
5378474 Sustained release pharmaceutical composition 171 1993
 
CIBA-GEIGY CORPORATION (1)
4548990 Crosslinked, porous polymers for controlled drug delivery 140 1983
 
HOECHST AKTIENGESELLSCHAFT (1)
4935246 Process for the coating of granules 126 1988
 
ARCHIMEDES DEVELOPMENT LIMITED (1)
5629011 Composition for nasal administration 96 1994
 
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (1)
4464378 Method of administering narcotic antagonists and analgesics and novel dosage forms containing same 219 1981
 
DRUGTECH CORPORATION (2)
5122384 Oral once-per-day organic nitrate formulation which does not induce tolerance 57 1989
5133974 Extended release pharmaceutical formulations 316 1990
 
MILES INC. (1)
4797410 Suppression of withdrawal symptoms in opioid-induced tolerance or dependence 51 1987
 
FMC CORPORATION (3)
5206030 Film-forming composition and use for coating pharmaceuticals, foods and the like 67 1990
5248516 Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like 55 1991
5258436 Film-forming composition; method of producing same and use for coating pharmaceuticals and foods and the like 45 1991
 
DepoMed Systems, Inc. (1)
5007790 Sustained-release oral drug dosage form 186 1989
 
GLATT GMBH (1)
5132142 Apparatus and method for producing pellets by layering power onto particles 74 1991
 
Merck Sharp & Dohme I.A. Corp. (1)
4377568 Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same 80 1981
 
GACELL LABORATORIES AB (3)
4557925 Membrane-coated sustained-release tablets and method 122 1984
5178868 Dosage form 76 1991
5520931 Controlled release morphine preparation 68 1995
 
WARNER-LAMBERT COMPANY (4)
4483847 Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material 92 1983
4600645 Process for treating dosage forms 78 1985
5068110 Stabilization of enteric coated dosage form 81 1989
5167964 Semi-enteric drug delivery systems and methods for preparing same 96 1992
 
CADBURY ADAMS USA LLC (1)
4894234 Novel drug delivery system for antiarrhythmics 92 1988
 
FOREST LABORATORIES, INC. (1)
4389393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 320 1982
 
PURDUE PHARMA COMPANY, THE (2)
4861598 Controlled release bases for pharmaceuticals 242 1986
4970075 Controlled release bases for pharmaceuticals 208 1989
 
FISONS CORPORATION (1)
4959219 Coating barriers comprising ethyl cellulose 51 1988
 
WATSON LABORATORIES, INC. (1)
4806337 Erodible matrix for sustained release bioactive composition 154 1986
 
ROHM GMBH (1)
4520172 Method for coating medicaments 62 1983
 
SPRING AG METALLWARENFABRIKEN AG (1)
5292461 Process for the production of pellets 78 1991
 
F.H. FAULDING & CO. LIMITED (1)
5196203 Theophylline dosage form 63 1991
 
AMERICAN CYANAMID COMPANY (1)
5283065 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form 115 1992
 
PUREUE PHARMA L.P. (1)
4834984 Controlled release dihydrocodeine composition 176 1987
 
DUQUESNE UNIVERSITY OF THE HOLY GHOST, A CORP. OF PA. (1)
5169645 Directly compressible granules having improved flow properties 163 1989
 
ZYMA SA (1)
4728513 Granular delayed-release form of pharmaceutically active substances 85 1986
 
TCF NATIONAL BANK (1)
5126145 Controlled release tablet containing water soluble medicament 132 1990
 
SHIONOGI & CO., LTD. (1)
5023089 Sustained-release preparations and the process thereof 68 1989
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
RECRO GAINESVILLE LLC (3)
9132096 Abuse resistant pharmaceutical compositions 1 2014
9486451 Abuse resistant pharmaceutical compositions 0 2015
9452163 Abuse resistant pharmaceutical compositions 0 2015
 
Other [Check patent profile for assignment information] (2)
9655893 Once-a-day oxycodone formulations 0 2014
9655894 Once-A day oxycodone formulations 0 2015
 
CIMA LABS INC. (4)
8445018 Abuse resistant drug formulation 20 2008
8927025 Alcohol-resistant metoprolol-containing extended-release oral dosage forms 1 2011
9572803 Abuse resistant drug formulation 0 2012
9216176 Abuse resistant drug formulation 0 2015
 
Pharmaceutical Manufacturing Research Services, Inc. (1)
9492444 Extruded extended release abuse deterrent pill 0 2014
 
EURO-CELTIQUE S.A. (1)
* 2004/0170,680 Once-a-day oxycodone formulations 103 2004
 
DEPOMED, INC. (10)
8377453 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 13 2009
* 2010/0015,222 GASTRIC RETENTIVE EXTENDED-RELEASE DOSAGE FORMS COMPRISING COMBINATIONS OF A NON-OPIOID ANALGESIC AND AN OPIOID ANALGESIC 22 2009
9161911 Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders 0 2009
* 2010/0040,689 GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERS 28 2009
8372432 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 8 2009
* 2010/0196,474 Gastric Retentive Extended-Release Dosage Forms Comprising Combinations of a Non-Opioid Analgesic and an Opioid Analgesic 15 2009
* 2011/0052,685 GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR IMMEDIATE AND EXTENDED RELEASE OF ACETAMINOPHEN 17 2010
8394408 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 21 2012
8668929 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2012
9566258 Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders 0 2015
 
SYNCHRONEURON INC. (3)
9421178 Acamprosate formulations, methods of using the same, and combinations comprising the same 0 2013
9421179 Acamprosate formulations, methods of using the same, and combinations comprising the same 0 2013
9427420 Acamprosate formulations, methods of using the same, and combinations comprising the same 0 2014
 
PURDUE PHARMA L.P. (22)
* 7846476 Once-a-day oxycodone formulations 42 2002
* 2011/0104,214 ONCE-A-DAY OXYCODONE FORMULATIONS 11 2010
8980291 Controlled release hydrocodone formulations 3 2010
* 8551520 Controlled release hydrocodone 29 2012
8975271 Controlled release hydrocodone formulations 0 2013
* 9060940 Controlled release hydrocodone 7 2014
8975273 Controlled release hydrocodone formulations 1 2014
8951555 Controlled release hydrocodone formulations 10 2014
9023401 Controlled release hydrocodone formulations 11 2014
9056052 Controlled release hydrocodone formulations 10 2015
9056107 Controlled release hydrocodone formulations 0 2015
9320717 Controlled release hydrocodone formulations 0 2015
9278074 Controlled release hydrocodone formulations 0 2015
9289391 Controlled release hydrocodone formulations 5 2015
9205055 Controlled release hydrocodone formulations 5 2015
9205056 Controlled release hydrocodone formulations 5 2015
9198863 Controlled release hydrocodone formulations 5 2015
9572804 Controlled release hydrocodone formulations 0 2016
9572805 Controlled release hydrocodone formulations 0 2016
9526724 Controlled release hydrocodone formulations 0 2016
9517236 Controlled release hydrocodone formulations 0 2016
9504681 Controlled release hydrocodone formulations 0 2016
 
LOCL PHARMA, INC. (8)
9433625 Pharmaceutical compositions for treating or preventing pain 0 2014
9427407 Pharmaceutical compositions 0 2015
9402813 Pharmaceutical compositions 1 2015
9399022 Pharmaceutical compositions 1 2015
9393207 Pharmaceutical compositions 1 2015
9498444 Pharmaceutical compositions 0 2015
9387177 Pharmaceutical compositions 0 2015
9526704 Pharmaceutical compositions for treating or preventing pain 0 2016
 
MALLINCKRODT INC. (10)
9198861 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans 0 2011
8597681 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans 14 2011
9050335 Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia 4 2012
8858963 Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia 7 2012
8741885 Gastric retentive extended release pharmaceutical compositions 4 2012
8658631 Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia 6 2012
9433582 Gastric retentive extended release pharmaceutical compositions 0 2014
9539328 Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia 0 2014
9468636 Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia 0 2015
9629837 Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia 0 2015
 
EGALET LTD. (8)
8877241 Morphine controlled release system 3 2004
9005660 Immediate release composition resistant to abuse by intake of alcohol 3 2010
9023394 Formulations and methods for the controlled release of active drug substances 2 2013
8808745 Morphine polymer release system 7 2013
9044402 Abuse-deterrent pharmaceutical compositions for controlled release 2 2014
9642809 Controlled release pharmaceutical compositions for prolonged effect 0 2014
9375428 Morphine controlled release system 1 2014
9358295 Immediate release composition resistant to abuse by intake of alcohol 2 2015
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 7, 2020
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00